참고문헌 (101)

1. Lleó, A., Greenberg, S.M., Growdon, J.H.. CURRENT PHARMACOTHERAPY FOR ALZHEIMER'S DISEASE. Annual review of medicine, vol.57, 513-533.

   상세보기

2. Trends Neurosci. SMALL 245 27 2004 10.1016/j.tins.2004.03.006 

   상세보기

3. ALVAREZ A, INESTROSA NC: Acetylcholinesterase in Alzheimer’s disease: Its molecular interactions with the amyloid β peptide. In: Recent Trends in the Acetylcholinesterase System . Parveen M et al. (Eds), IOS Press, Amsterdam, The Netherlands (2005):11-22. 

4. Rees, T, Hammond, P.I, Soreq, H, Younkin, S, Brimijoin, S. Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex. Neurobiology of aging, vol.24, no.6, 777-787.

   상세보기

5. Biochem. Pharmacol. BARTOLINI 407 65 2003 10.1016/S0006-2952(02)01514-9 

   상세보기

6. J. Biol. Chem. BOURNE 2963 274 1999 10.1074/jbc.274.5.2963 

   상세보기

7. Curr. Pharm. Des. JOHNSON 217 12 2006 10.2174/138161206775193127 

   상세보기

8. Neurosci. Lett. STEFANOVA 159 338 2003 10.1016/S0304-3940(02)01384-8 

   상세보기

9. Neuroreport VENNERI 83 13 2002 10.1097/00001756-200201210-00020 

   상세보기

10. J. Neurol. Sci. LOJKOWSKA 119 216 2003 10.1016/S0022-510X(03)00229-6 

    상세보기

11. Acta Psychiatr. Scand. MAIDMENT 403 111 2005 10.1111/j.1600-0447.2005.00516.x 

    상세보기

12. J. Neurol. BOHNEN 242 253 2006 10.1007/s00415-005-0971-0 

    상세보기

13. Poewe, Werner, Wolters, Erik, Emre, Murat, Onofrj, Marco, Hsu, Chuanchieh, Tekin, Sibel, Lane, Roger. Long‐term benefits of rivastigmine in dementia associated with Parkinson's disease: An active treatment extension study. Movement disorders : official journal of the Movement Disorder Society, vol.21, no.4, 456-461.

    상세보기

14. Int. J. Geriatr. Psychiatry VAN DER PUTT 755 21 2006 10.1002/gps.1557 

    상세보기

15. Arch. Gerontol. Geriatr. RAMPELLO 1 39 2004 10.1016/j.archger.2003.11.003 

    상세보기

16. J. Psychopharmacol. ALWAHHABI 214 19 2005 10.1177/0269881105049045 

    상세보기

17. J. Neuropsychiatry Clin. Neurosci. SIMARD 409 16 2004 10.1176/jnp.16.4.409 

    상세보기

18. CNS Drugs ERKINJUNTTI 35 12 1999 10.2165/00023210-199912010-00004 

    상세보기

19. Moretti, Rita, Torre, Paola, Antonello, Rodolfo M., Cazzato, Giuseppe, Griggio, Stefania, Bava, Antonio. An open-label pilot study comparing rivastigmine and low-dose aspirin for the treatment of symptoms specific to patients with subcortical vascular dementia. Current therapeutic research, vol.63, no.7, 443-458.

    상세보기

20. Am. J. Alzheimers Dis. Demen. MORETTI 333 19 2004 10.1177/153331750401900607 

    상세보기

21. Mov. Disord. FERNANDEZ 173 15 2000 10.1002/1531-8257(200001)15:1<173::AID-MDS1032>3.0.CO;2-T 

    상세보기

22. Int. J. Clin. Psychopharmacol. PETRIKIS 49 19 2004 10.1097/00004850-200401000-00010 

    상세보기

23. Proc. Natl. Acad. Sci. USA STERNFELD 8647 97 2000 10.1073/pnas.140004597 

    상세보기

24. 10.1097/01.wad.0000213804.59187.2d 

    

25. Curr. Protein Pept. Sci. HOLMQUIST 209 1 2000 10.2174/1389203003381405 

    상세보기

26. Science SUSSMAN 872 253 1991 10.1126/science.1678899 

    상세보기

27. Ann. Pharmacotherapy CRISMON 744 28 1994 10.1177/106002809402800612 

    상세보기

28. J. Clin. Pharm. Ther. MISSON 251 22 1997 10.1046/j.1365-2710.1997.10275102.x 

    상세보기

29. Drugs SCOTT 1095 60 2000 10.2165/00003495-200060050-00008 

    상세보기

30. Br. J. Clin. Pharmacol. MCGLEENON 471 48 1999 10.1046/j.1365-2125.1999.00026.x 

    상세보기

31. Mol. Brain Res. WANG 1 107 2002 10.1016/S0169-328X(02)00402-3 

    상세보기

32. Zhao, Qin, Tang, Xi Can. Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine. European journal of pharmacology, vol.455, no.2, 101-107.

    상세보기

33. Proc. Natl. Acad. Sci. USA HAREL 9031 90 1993 10.1073/pnas.90.19.9031 

    상세보기

34. Biochem. Soc. Trans. SILMAN 745 22 1994 10.1042/bst0220745 

    상세보기

35. Structure KRYGER 297 7 1999 10.1016/S0969-2126(99)80040-9 

    상세보기

36. J. Med. Chem. RYDBERG 5491 49 2006 10.1021/jm060164b 

    상세보기

37. Lancet DAVIS 625 345 1995 10.1016/S0140-6736(95)90526-X 

    상세보기

38. Blackard Jr., William G., Sood, Gagan K., Crowe, D. Ralph, Fallon, Michael B.. Tacrine : A Cause of Fatal Hepatotoxicity?. Journal of clinical gastroenterology, vol.26, no.1, 57-59.

    상세보기

39. Muñoz-Torrero, D, Camps, P. Dimeric and hybrid anti-Alzheimer drug candidates.. Current medicinal chemistry, vol.13, no.4, 399-422.

    상세보기

40. Jpn. J. Pharmacol. SUGIMOTO 7 89 2002 10.1254/jjp.89.7 

    상세보기

41. Br. J. Clin. Pharmacol. JACKSON 1 58 2004 10.1111/j.1365-2125.2004.01848.x 

    상세보기

42. Br. J. Clin. Pharmacol. REYES 9 58 2004 10.1111/j.1365-2125.2004.01802.x 

    상세보기

43. Dement. Geriatr. Cogn. Disord. LILIENFELD 19 11 2000 10.1159/000051228 

    상세보기

44. Santos, Máriton D., Alkondon, Manickavasagom, Pereira, Edna F. R., Aracava, Yasco, Eisenberg, Howard M., Maelicke, Alfred, Albuquerque, Edson X.. The Nicotinic Allosteric Potentiating Ligand Galantamine Facilitates Synaptic Transmission in the Mammalian Central Nervous System. Molecular pharmacology, vol.61, no.5, 1222-1234.

    상세보기

45. Methods Find. Exp. Clin. Pharmacol. ALES 151 24 2002 10.1358/mf.2002.24.3.802300 

    상세보기

46. J. Mol. Graphics Model PILGER 288 19 2001 10.1016/S1093-3263(00)00056-5 

    상세보기

47. Arias, Esperanza, Alés, Eva, Gabilan, Nelson H., Cano-Abad, María F., Villarroya, Mercedes, García, Antonio G., López, Manuela G.. Galantamine prevents apoptosis induced by β-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors. Neuropharmacology, vol.46, no.1, 103-114.

    상세보기

48. Drugs Fut. TANG 647 24 1999 10.1358/dof.1999.024.06.545143 

    상세보기

49. J. Biol. Chem. PANG 23646 271 1996 10.1074/jbc.271.39.23646 

    상세보기

50. J. Am. Chem. Soc. WONG 363 125 2003 10.1021/ja021111w 

    상세보기

51. Zangara, Andrea. The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease. Pharmacology, biochemistry, and behavior, vol.75, no.3, 675-686.

    상세보기

52. Drug. Fut. BRUFANI 379 22 1997 

53. Clin. Ther. RONALD 634 20 1998 10.1016/S0149-2918(98)80127-6 

    상세보기

54. Shaw, Karen T. Y., Utsuki, Tadanobu, Rogers, Jack, Yu, Qian-Sheng, Sambamurti, Kumar, Brossi, Arnold, Ge, Yuan-Wen, Lahiri, Debomoy K., Greig, Nigel H.. Phenserine regulates translation of β-amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development. Proceedings of the National Academy of Sciences of the United States of America, vol.98, no.13, 7605-7610.

    상세보기

55. Utsuki, Tada, Yu, Qian-sheng, Davidson, Diane, Chen, Demao, Holloway, Harold W., Brossi, Arnold, Sambamurti, Kumar, Lahiri, Debomoy K., Greig, Nigel H., Giordano, Tony. Identification of Novel Small Molecule Inhibitors of Amyloid Precursor Protein Synthesis as a Route to Lower Alzheimer's Disease Amyloid-β Peptide. The Journal of pharmacology and experimental therapeutics, vol.318, no.2, 855-862.

    상세보기

56. Martinez, Ana, Castro, Ana. Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer’s disease. Expert opinion on investigational drugs, vol.15, no.1, 1-12.

    상세보기

57. Prog. Brain Res. ENZ 431 98 1993 10.1016/S0079-6123(08)62429-2 

    상세보기

58. Cutler, N. R., Polinsky, R. J., Srarnek, J. J., Enz, A., Jhee, S. S., Mancione, L., Hourani, J., Zolnouni, P.. Dose-dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer's disease. Acta neurologica Scandinavica, vol.97, no.4, 244-250.

    상세보기

59. Eur. Neurol. BALLARD 64 47 2002 10.1159/000047952 

    상세보기

60. Neuroreport VENNERI 107 16 2005 10.1097/00001756-200502080-00006 

    상세보기

61. Pharmacol. Res. GIACOBINI 433 50 2004 10.1016/j.phrs.2003.11.017 

    상세보기

62. Greig, Nigel H., Lahiri, Debomoy K., Sambamurti, Kumar. Butyrylcholinesterase: An Important New Target in Alzheimer's Disease Therapy. International psychogeriatrics, vol.14, no.suppl1, 77-91.

    상세보기

63. Int. J. Clin. Pract. WILKINSON 441 56 2002 10.1111/j.1742-1241.2002.tb11294.x 

    상세보기

64. Eur. J. Pharmacol. LISTON 9 486 2004 10.1016/j.ejphar.2003.11.080 

    상세보기

65. Med. Chem. Rev. GREIG 3 15 1995 

66. Carlier, P.R., Han, Y.F., Chow, E.S.H., Li, C.P.L., Wang, H., Xuan Lieu, T., Sum Wong, H., Pang, Y.P.. Evaluation of short-tether Bis-THA AChE inhibitors. A further test of the dual binding site hypothesis. Bioorganic & medicinal chemistry, vol.7, no.2, 351-357.

    상세보기

67. Neurosci. Lett. LIU 165 282 2000 10.1016/S0304-3940(00)00905-8 

    상세보기

68. Neurosci. Lett. WU 95 288 2000 10.1016/S0304-3940(00)01198-8 

    상세보기

69. J. Biol. Chem. LI 18179 280 2005 10.1074/jbc.M411085200 

    상세보기

70. J. Med. Chem. CARLIER 4225 42 1999 10.1021/jm990224w 

    상세보기

71. J. Med. Chem. RECANATINI 2007 43 2000 10.1021/jm990971t 

    상세보기

72. J. Med. Chem. HU 2277 45 2002 10.1021/jm010308g 

    상세보기

73. Gregor, V.E., Emmerling, M.R., Lee, C., Moore, C.J.. The synthesis and in vitro acetylcholinesterase and butyrylcholinesterase inhibitory activity of tacrine (Cognex®) derivaties. Bioorganic & medicinal chemistry letters, vol.2, no.8, 861-864.

    상세보기

74. Biopolymers WLODEK 109 38 1996 10.1002/(SICI)1097-0282(199601)38:1<109::AID-BIP9>3.0.CO;2-# 

    상세보기

75. Dvir, H., Wong, D. M., Harel, M., Barril, X., Orozco, M., Luque, F. J., Munoz-Torrero, D., Camps, P., Rosenberry, T. L., Silman, I., Sussman, J. L.. 3D Structure of Torpedo californica Acetylcholinesterase Complexed with Huprine X at 2.1 Å Resolution: Kinetic and Molecular Dynamic Correlates^,. Biochemistry, vol.41, no.9, 2970-2981.

    상세보기

76. Munoz-Ruiz, P., Rubio, L., Garcia-Palomero, E., Dorronsoro, I., del Monte-Millan, M., Valenzuela, R., Usan, P., de Austria, C., Bartolini, M., Andrisano, V., Bidon-Chanal, A., Orozco, M., Luque, F. J., Medina, M., Martinez, A.. Design, Synthesis, and Biological Evaluation of Dual Binding Site Acetylcholinesterase Inhibitors: New Disease-Modifying Agents for Alzheimer's Disease. Journal of medicinal chemistry, vol.48, no.23, 7223-7233.

    상세보기

77. Mini-Rev. Med.Chem. BARRIL 27 2 2002 10.2174/1389557023406494 

    상세보기

78. J. Med. Chem. SAVINI 1 46 2003 10.1021/jm0255668 

    상세보기

79. J. Med. Chem. CAMPIANI 1919 48 2005 10.1021/jm049510k 

    상세보기

80. Bioorg. Med. Chem. Lett. SHAO 4639 14 2004 10.1016/j.bmcl.2004.07.005 

    상세보기

81. Bioorg. Med. Chem. ALONSO 6588 13 2005 10.1016/j.bmc.2005.09.029 

    상세보기

82. Rosini, M., Andrisano, V., Bartolini, M., Bolognesi, M. L., Hrelia, P., Minarini, A., Tarozzi, A., Melchiorre, C.. Rational Approach To Discover Multipotent Anti-Alzheimer Drugs. Journal of medicinal chemistry, vol.48, no.2, 360-363.

    상세보기

83. J. Med. Chem. RODRIGUEZ-FRANCO 459 49 2006 10.1021/jm050746d 

    상세보기

84. Bolognesi, M. L., Andrisano, V., Bartolini, M., Banzi, R., Melchiorre, C.. Propidium-Based Polyamine Ligands as Potent Inhibitors of Acetylcholinesterase and Acetylcholinesterase-Induced Amyloid-&bgr; Aggregation. Journal of medicinal chemistry, vol.48, no.1, 24-27.

    상세보기

85. J. Med. Chem. ROSINI 1860 45 2002 10.1021/jm011067f 

    상세보기

86. J. Med. Chem. BOLOGNESI 3286 45 2002 10.1021/jm020835f 

    상세보기

87. J. Med. Chem. TUMIATTI 954 46 2003 10.1021/jm021055+ 

    상세보기

88. Proc. Natl. Acad. Sci. USA BOURNE 1449 101 2004 10.1073/pnas.0308206100 

    상세보기

89. J. Am. Chem. Soc. KRASINSKI 6686 127 2005 10.1021/ja043031t 

    상세보기

90. Synapse LIU 57 13 1993 10.1002/syn.890130108 

    상세보기

91. J. Med. Chem. FENG 655 48 2005 10.1021/jm0496178 

    상세보기

92. Bioorg. Med. Chem. Lett. CARLIER 2335 9 1999 10.1016/S0960-894X(99)00396-0 

    상세보기

93. Camps, P., El Achab, R., Morral, J., Munoz-Torrero, D., Badia, A., Banos, J. E., Vivas, N. M., Barril, X., Orozco, M., Luque, F. J.. New Tacrine−Huperzine A Hybrids (Huprines): Highly Potent Tight-Binding Acetylcholinesterase Inhibitors of Interest for the Treatment of Alzheimer's Disease. Journal of medicinal chemistry, vol.43, no.24, 4657-4666.

    상세보기

94. Neuropharmacology DEL MAR ALCALÁ 749 44 2003 10.1016/S0028-3908(03)00071-6 

    상세보기

95. Canudas, Anna M, Pubill, David, Sureda, Francesc X, Verdaguer, Ester, Camps, Pelayo, Muñoz-Torrero, Diego, Jiménez, Andrés, Camins, Antoni, Pallàs, Mercè. Neuroprotective effects of (±)-huprine Y on in vitro and in vivo models of excitoxicity damage. Experimental neurology, vol.180, no.2, 123-130.

    상세보기

96. Camps, P., Formosa, X., Munoz-Torrero, D., Petrignet, J., Badia, A., Clos, M. V.. Synthesis and Pharmacological Evaluation of Huprine−Tacrine Heterodimers: Subnanomolar Dual Binding Site Acetylcholinesterase Inhibitors. Journal of medicinal chemistry, vol.48, no.6, 1701-1704.

    상세보기

97. Bioorg. Med. Chem. Lett. MARY 835 6 1998 10.1016/S0968-0896(98)00133-3 

    상세보기

98. Bioorg. Med. Chem. Lett. GUILLOU 637 10 2000 10.1016/S0960-894X(00)00059-7 

    상세보기

99. Proteins: Struct. Funct. Genet. BARTOLUCCI 182 42 2001 10.1002/1097-0134(20010201)42:2<182::AID-PROT50>3.0.CO;2-1 

    상세보기

100. J. Pharm. Pharmacol. ALPTÜZÜN 1397 55 2003 10.1211/0022357021855 

     상세보기

101. Bioorg. Med. Chem. KAPKOVÁ 472 14 2006 10.1016/j.bmc.2005.08.034 

     상세보기